Skip to main content

Articles

Page 53 of 71

  1. The role of adjuvant radiotherapy (RT) for patients with stage III thymoma after complete resection is not definite. Some authors have advocated postoperative RT after complete tumor resection, but some others...

    Authors: Chengcheng Fan, Qinfu Feng, Yidong Chen, Yirui Zhai, Zongmei Zhou, Dongfu Chen, Zefen Xiao, Hongxing Zhang, Jian Li, Zhouguang Hui, Jun Liang, Jima Lv, Yousheng Mao, Luhua Wang and Jie He
    Citation: Radiation Oncology 2013 8:199
  2. Increasing the radiotherapy dose can result in improved local control for non-small-cell lung cancer (NSCLC) and can thereby improve survival. Accelerated hypofractionated radiotherapy can expose tumors to a h...

    Authors: Yue-E Liu, Qiang Lin, Fan-Jie Meng, Xue-Ji Chen, Xiao-Cang Ren, Bin Cao, Na Wang, Jie Zong, Yu Peng, Ya-Jun Ku and Yan Chen
    Citation: Radiation Oncology 2013 8:198
  3. Treating prostate cancer with SBRT could potentially minimize radiation proctitis by reducing high-dose rectal irradiation. In addition, it offers the potential radiobiologic benefits of hypofractionation. Thi...

    Authors: Sumit Sood, Andrew W Ju, Honkung Wang, Siyuan Lei, Sunghae Uhm, Guowei Zhang, Simeng Suy, John Carroll, John Lynch, Anatoly Dritschilo and Sean P Collins
    Citation: Radiation Oncology 2013 8:197
  4. To determine the biological effectiveness of single, fractionated and continuous low dose rate irradiation on the human colorectal cancer cell line CL187 in vitro and explore the cellular mechanisms.

    Authors: Hao Wang, Jinna Li, Ang Qu, Jingjia Liu, Yong Zhao and Junjie Wang
    Citation: Radiation Oncology 2013 8:196
  5. Glioma stem cells in the quiescent state are resistant to clinical radiation therapy. An almost inevitable glioma recurrence is due to the persistence of these cells. The high linear energy transfer associated...

    Authors: Ting Sun, Zizhu Zhang, Bin Li, Guilin Chen, Xueshun Xie, Yongxin Wei, Jie Wu, Youxin Zhou and Ziwei Du
    Citation: Radiation Oncology 2013 8:195
  6. We describe five patients receiving a re-implantation (RI) after post-operative dosimetry of the primary 125-I permanent prostate brachytherapy (BT) for prostate cancer revealed an insufficient dose coverage.

    Authors: Paul Martin Putora, Ludwig Plasswilm, Wolf Seelentag, Johann Schiefer, Patrick Markart, Hans-Peter Schmid and Daniel Engeler
    Citation: Radiation Oncology 2013 8:194
  7. The modulated arc (mARC) technique has recently been introduced by Siemens as an analogue to VMAT treatment. However, up to now only one certified treatment planning system supports mARC planning. We therefore...

    Authors: Yvonne Dzierma, Frank Nuesken, Norbert Licht and Christian Ruebe
    Citation: Radiation Oncology 2013 8:193
  8. Radiologic response of brain tumors is traditionally assessed according to the Macdonald criteria 10 weeks from the start of therapy. Because glioblastoma (GB) responds in days rather than weeks after boron ne...

    Authors: Ryo Hiramatsu, Shinji Kawabata, Motomasa Furuse, Shin-Ichi Miyatake and Toshihiko Kuroiwa
    Citation: Radiation Oncology 2013 8:192
  9. The Montpellier cancer institute phase II trial started in 2004 and evaluated the feasibility of intraoperative radiotherapy (IORT) technique given as a sole radiation treatment for patients with an excellent ...

    Authors: Claire Lemanski, David Azria, Sophie Gourgou-Bourgade, Norbert Ailleres, Aurelie Pastant, Philippe Rouanet, Pascal Fenoglietto, Jean-Bernard Dubois and Marian Gutowski
    Citation: Radiation Oncology 2013 8:191
  10. The prognosis of prostate cancer patients with lymph node metastases so small they can only be visualized by new imaging techniques as MR lymphography (MRL) is unknown. The purpose of this study was to investi...

    Authors: Hanneke JM Meijer, Oscar A Debats, Emile NJTh van Lin, Johannes Alfred Witjes, Johannes HAM Kaanders and Jelle O Barentsz
    Citation: Radiation Oncology 2013 8:190
  11. The vascular endothelial cells are important targets of radiotherapy, which may be involved in the pathogenesis of radiation pneumonitis (RP). This study investigated the variations of circulating endothelial ...

    Authors: Yunfang Liu, Tingyi Xia, Wenjun Zhang, Yongjie Zhong, Luhua Zhang, Xuan Wang and Huiming Yu
    Citation: Radiation Oncology 2013 8:189
  12. Increasing use of IMRT to treat breast and prostate cancers at high risk of regional nodal spread relies on accurate contouring of targets and organs at risk, which is subject to significant inter- and intra-o...

    Authors: Vikram M Velker, George B Rodrigues, Robert Dinniwell, Jeremiah Hwee and Alexander V Louie
    Citation: Radiation Oncology 2013 8:188
  13. Neurocognitive decline observed after radiotherapy (RT) for brain tumors in long time survivors is attributed to radiation exposure of the hippocampus and the subventricular zone (SVZ). The potential of sparin...

    Authors: Julia Oehler, Tim Brachwitz, Thomas G Wendt, Nico Banz, Mario Walther and Tilo Wiezorek
    Citation: Radiation Oncology 2013 8:187
  14. In-room cone-beam computerized tomography (CBCT) imaging is a promising method to reduce setup errors, especially in organs such as the bladder that often have large intrafractional variations due to organ mov...

    Authors: Kentaro Nishioka, Shinichi Shimizu, Rumiko Kinoshita, Tetsuya Inoue, Shunsuke Onodera, Koichi Yasuda, Keiichi Harada, Yukiko Nishikawa, Rikiya Onimaru and Hiroki Shirato
    Citation: Radiation Oncology 2013 8:185
  15. Hodgkin disease (HD) and medulloblastoma (MB) are common malignancies found in children and young adults, and radiotherapy is part of the standard treatment. It was reported that these patients who received ra...

    Authors: Rui Zhang, Rebecca M Howell, Kenneth Homann, Annelise Giebeler, Phillip J Taddei, Anita Mahajan and Wayne D Newhauser
    Citation: Radiation Oncology 2013 8:184
  16. To evaluate the interobserver variability of gross tumor volume (GTV) - delineation of Dominant Intraprostatic Lesions (DIPL) in patients with prostate cancer using published MRI criteria for multiparametric M...

    Authors: Hans Christian Rischke, Ursula Nestle, Tobias Fechter, Christian Doll, Natalja Volegova-Neher, Karl Henne, Jutta Scholber, Stefan Knippen, Simon Kirste, Anca L Grosu and Cordula A Jilg
    Citation: Radiation Oncology 2013 8:183
  17. Tomotherapy for intensity-modulated radiation has been demonstrated to reduce unnecessary irradiations to adjacent organs at risk (OARs). The purpose of this study was to compare the dosimetric parameters betw...

    Authors: Mina Yu, Joo Hwan Lee, Hong Seok Jang, Dong Min Jeon, Jae Suk Cheon, Hyo Chun Lee and Jong Hoon Lee
    Citation: Radiation Oncology 2013 8:181
  18. This study compared manually delineated gross tumour volume (GTV) and automatically generated biological tumour volume (BTV) based on fluoro-deoxy-glucose (FDG) positron emission tomography (PET)/CT to assess ...

    Authors: Maximilian Niyazi, Sonja Landrock, Andreas Elsner, Farkhad Manapov, Marcus Hacker, Claus Belka and Ute Ganswindt
    Citation: Radiation Oncology 2013 8:180
  19. Low survival outcomes have been reported for the treatment of locally advanced non small cell lung cancer (LA-NSCLC) with the standard of care treatment of concurrent chemoradiation (cCRT). We present our expe...

    Authors: Sana D Karam, Zachary D Horne, Robert L Hong, Don McRae, David Duhamel and Nadim M Nasr
    Citation: Radiation Oncology 2013 8:179
  20. Radioresistance is the common cause for radiotherapy failure in non-small cell lung cancer (NSCLC), and the degree of radiosensitivity of tumor cells is different during different cell cycle phases. The object...

    Authors: Rubo Cao, Qian Ding, Pindong Li, Jun Xue, Zhenwei Zou, Jing Huang and Gang Peng
    Citation: Radiation Oncology 2013 8:178
  21. To determine prostate volume (Pvol) changes at 3 different time points during the course of I125 permanent seed brachytherapy (PB). To assess the impact of these changes on acute urinary retention (AUR) and dosim...

    Authors: Ciprian Chira, Guila Delouya, Sandra Larrivée, Jean-Francois Carrier and Daniel Taussky
    Citation: Radiation Oncology 2013 8:177
  22. To assess the dosimetric effect induced by inter-observer variability in target definition for 3D-conformal RT (3DCRT) and volumetric modulated arc therapy by RapidArc (RA) techniques for rectal cancer treatment.

    Authors: Francesca Lobefalo, Mario Bignardi, Giacomo Reggiori, Angelo Tozzi, Stefano Tomatis, Filippo Alongi, Antonella Fogliata, Anna Gaudino, Piera Navarria, Luca Cozzi, Marta Scorsetti and Pietro Mancosu
    Citation: Radiation Oncology 2013 8:176
  23. Local ablative therapies such as stereotactically guided single-dose radiotherapy or helical intensity-modulated radiotherapy (tomotherapy) with high single-doses are successfully applied in many centers in pa...

    Authors: Daniel Habermehl, Klaus K Herfarth, Justo Lorenzo Bermejo, Holger Hof, Stefan Rieken, Sabine Kuhn, Thomas Welzel, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2013 8:175
  24. Tumor human papillomavirus (HPV) status has emerged as one of the most powerful prognostic factors for disease control and survival in patients with oropharyngeal squamous cell carcinoma (OPSCC). We reviewed o...

    Authors: Trevor J Bledsoe, Anisha R Noble, Grant K Hunter, Lisa A Rybicki, Aaron Hoschar, Deborah J Chute, Jerrold P Saxton, John F Greskovich, David J Adelstein and Shlomo A Koyfman
    Citation: Radiation Oncology 2013 8:174
  25. Accumulating evidence suggests that brachial plexopathy following head and neck cancer radiotherapy may be underreported and that this toxicity is associated with a dose–response. Our purpose was to determine ...

    Authors: Robert W Mutter, Benjamin H Lok, Pinaki R Dutta, Nadeem Riaz, Jeremy Setton, Sean L Berry, Anuj Goenka, Zhigang Zhang, Shyam S Rao, Suzanne L Wolden and Nancy Y Lee
    Citation: Radiation Oncology 2013 8:173
  26. A review of planning studies was undertaken to evaluate estimated risks of radiation induced second primary cancers (RISPC) associated with different prostate radiotherapy techniques for localised prostate can...

    Authors: Louise Murray, Ann Henry, Peter Hoskin, Frank-Andre Siebert and Jack Venselaar
    Citation: Radiation Oncology 2013 8:172
  27. To evaluate the feasibility and early side effects of a short course hypo-fractionated SBRT programme with Volumetric Modulated Arc Therapy (VMAT) and Flattening Filter Free (FFF) beams.

    Authors: Filippo Alongi, Luca Cozzi, Stefano Arcangeli, Cristina Iftode, Tiziana Comito, Elisa Villa, Francesca Lobefalo, Pierina Navarria, Giacomo Reggiori, Pietro Mancosu, Elena Clerici, Antonella Fogliata, Stefano Tomatis, Gianluigi Taverna, Pierpaolo Graziotti and Marta Scorsetti
    Citation: Radiation Oncology 2013 8:171
  28. The ideal prostate-specific antigen (PSA) doubling time (PSADT) threshold for identifying patients at high-risk for poor clinical outcome following salvage radiation therapy (SRT) has not been well established...

    Authors: William C Jackson, Skyler B Johnson, Darren Li, Corey Foster, Benjamin Foster, Yeohan Song, Matthew Schipper, Mark Shilkrut, Howard M Sandler, Todd M Morgan, Ganesh S Palapattu, Daniel A Hamstra and Felix Y Feng
    Citation: Radiation Oncology 2013 8:170
  29. To analyze the longitudinal length accuracy of gross tumor volume (GTV) delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma (SCC).

    Authors: Dong-Liang Hou, Gao-Feng Shi, Xian-Shu Gao, Junichi Asaumi, Xue-Ying Li, Hui Liu, Chen Yao and Joe Y Chang
    Citation: Radiation Oncology 2013 8:169
  30. Lung stereotactic ablative radiotherapy (SABR) has recently become more common in the management of patients with early-stage non-small cell lung cancer (NSCLC) and metastatic lung lesions who are not surgical...

    Authors: Michael C Stauder, Jessica W Rooney, Michelle A Neben-Wittich, Yolanda I Garces and Kenneth R Olivier
    Citation: Radiation Oncology 2013 8:167
  31. The purpose of this study was to analyze the efficacy and tolerability of palliative radiotherapy (RT) in patients with a poor performance status (PS) and to evaluate the relationship between the palliative ef...

    Authors: Shinsaku Yamaguchi, Takayuki Ohguri, Yuichi Matsuki, Katsuya Yahara, Hiroyuki Narisada, Hajime Imada and Yukunori Korogi
    Citation: Radiation Oncology 2013 8:166
  32. To evaluate the therapeutic benefit of 3D-image-guided high-dose-rate intracavitary brachytherapy (3D-image-guided HDR-BT) used as a salvage treatment of intensity modulated radiation therapy (IMRT) in patient...

    Authors: Yu Feng Ren, Xin Ping Cao, Jia Xu, Wei Jun Ye, Yuan Hong Gao, Bin S Teh and Bi Xiu Wen
    Citation: Radiation Oncology 2013 8:165
  33. Localization of the tumor bed of breast cancer is crucial for accurate planning of boost irradiation. Lumpectomy cavity and surgical clips provide localizing information about tumor bed. However, defining the ...

    Authors: Oyeon Cho, Mison Chun, Young Taek Oh, Mi Hwa Kim, Hae Jin Park, Jae Sung Heo and O Kyu Noh
    Citation: Radiation Oncology 2013 8:163
  34. This retrospective study investigated the outcome of patients with brain metastases after radiosurgery with special emphasis on prognostic impact of visible intratumoral necrosis on survival and local control.

    Authors: Kristina Martens, Thekla Meyners, Dirk Rades, Volker Tronnier, Matteo Mario Bonsanto, Dirk Petersen, Jürgen Dunst and Kathrin Dellas
    Citation: Radiation Oncology 2013 8:162
  35. First, to evaluate outcome, the benefit of concurrent chemotherapy and prognostic factors in a cohort of sixty-four high-grade glioma patients who underwent a second course of radiation therapy at progression....

    Authors: Felix Scholtyssek, Isabella Zwiener, Annika Schlamann, Clemens Seidel, Jürgen Meixensberger, Manfred Bauer, Karl-Titus Hoffmann, Stephanie E Combs, André O von Bueren, Rolf-Dieter Kortmann and Klaus Müller
    Citation: Radiation Oncology 2013 8:161
  36. Although capecitabine has theoretical advantages in the pharmacokinetics, such as higher intratumoral and lower systemic concentration, relative to bolus 5-fluorouracil (5-FU), outcomes of chemoradiotherapy (C...

    Authors: Yeon-Joo Kim, Woo Jin Lee, Sang Myung Woo, Tae Hyun Kim, Sung Sik Han, Bo Hyun Kim, Sung Ho Moon, Sang Soo Kim, Young Hwan Koh, Sang Jae Park, Joo Young Kim, Dae Yong Kim and Joong Won Park
    Citation: Radiation Oncology 2013 8:160
  37. Hormone-resistant (HR) prostate cancers are highly aggressive and respond poorly to treatment. IL-6/STAT3 signaling has been identified to link with the transition of HR and aggressive tumor behavior. The role...

    Authors: Chun-Te Wu, Miao-Fen Chen, Wen-Cheng Chen and Ching-Chuan Hsieh
    Citation: Radiation Oncology 2013 8:159
  38. Stereotactic body radiotherapy and radiosurgery are rapidly emerging treatment options for both malignant and benign spine tumors. Proper institutional credentialing by physicians and medical physicists as wel...

    Authors: Peter C Gerszten, Arjun Sahgal, Jason P Sheehan, Ronald Kersh, Stephanie Chen, John C Flickinger, Mubina Quader, Daniel Fahim, Inga Grills, John H Shin, Brian Winey, Kevin Oh, Reinhart A Sweeney and Matthias Guckenberger
    Citation: Radiation Oncology 2013 8:158
  39. To evaluate the efficacy and toxicity of fractionated stereotactic radiotherapy (FSRT) in patients with residual nasopharyngeal carcinoma (NPC).

    Authors: Feng Liu, Jian-ping Xiao, Guo-zhen Xu, Li Gao, Ying-jie Xu, Ye Zhang, Xue-song Jiang, Jun-lin Yi, Jing-wei Luo, Xiao-dong Huang, Fu-kui Huan, Hao Fang, Bao Wan and Ye-xiong Li
    Citation: Radiation Oncology 2013 8:157
  40. The incidence of oligometastases to the brain in good performance status patients is increasing due to improvements in systemic therapy and MRI screening, but specific management pathways are often lacking.

    Authors: Jillian Maclean, Naomi Fersht, Mausam Singhera, Paul Mulholland, Orla McKee, Neil Kitchen and Susan C Short
    Citation: Radiation Oncology 2013 8:156
  41. To evaluate the role of γ-H2AX in peripheral blood lymphocytes (PBLs) as a predictive biomarker of the severity of oral mucositis (OM) in head and neck cancer (HNC) patients with receiving radiotherapy.

    Authors: Ping Li, Cheng-run Du, Wen-cai Xu, Ze-liang Shi, Qing Zhang, Zhao-bin Li and Shen Fu
    Citation: Radiation Oncology 2013 8:155
  42. Intensity modulated radiotherapy for head and neck cancer necessitates accurate definition of organs at risk (OAR) and clinical target volumes (CTV). This crucial step is time consuming and prone to inter- and...

    Authors: Jean-François Daisne and Andreas Blumhofer
    Citation: Radiation Oncology 2013 8:154
  43. The purpose of this study was to evaluate the impact of Cone Beam CT (CBCT) based setup correction on total dose distributions in fractionated frameless stereotactic radiation therapy of intracranial lesions.

    Authors: Petra Maria Haertl, Rainer Loeschel, Natalia Repp, Fabian Pohl, Oliver Koelbl and Barbara Dobler
    Citation: Radiation Oncology 2013 8:153
  44. This study was to compare radiotherapy treatment planning and treatment outcomes following three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in stage I-II natural kil...

    Authors: Qianwen Shen, Xuejun Ma, Weigang Hu, Lanfei Chen, Juan Huang and Ye Guo
    Citation: Radiation Oncology 2013 8:152
  45. Early stage breast cancer patients are long-term survivors and finding techniques that may lower acute and late radiotherapy-induced toxicity is crucial. We compared dosimetry of wedged tangential fields (W-TF...

    Authors: Thomas Mulliez, Bruno Speleers, Indira Madani, Werner De Gersem, Liv Veldeman and Wilfried De Neve
    Citation: Radiation Oncology 2013 8:151
  46. To investigate the feasibility and dosimetric improvements of a novel technique to temporarily displace critical structures in the pelvis and abdomen from tumor during high-dose radiotherapy.

    Authors: Evangelia Katsoulakis, Stephen B Solomon, Majid Maybody, Douglas Housman, Greg Niyazov, Nadeem Riaz, Michael Lovelock, Daniel E Spratt, Joseph P Erinjeri, Raymond H Thornton and Yoshiya Yamada
    Citation: Radiation Oncology 2013 8:150

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.3
    5-year Journal Impact Factor: 3.6
    Source Normalized Impact per Paper (SNIP): 1.197
    SCImago Journal Rank (SJR): 1.033

    Speed 2023
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 132

    Usage 2023
    Downloads: 1,958,690
    Altmetric mentions: 605